Today: March 23, 2017, 11:04 pm

WEX Pharmaceuticals Inc. - Strategic SWOT Analysis Review - New Market Research Report

New Pharmaceuticals market report from GlobalData: "WEX Pharmaceuticals Inc. - Strategic SWOT Analysis Review" 2014-03-01 16:38:25
WEX Pharmaceuticals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - GlobalData's summarization of the company's business strategy.
* SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.

Full Report Details at
- ..


WEX Pharmaceuticals Inc. (WEX) is a pharmaceutical company. The company carries out the discovery, development, manufacture and commercialization of new class therapeutics for the treatment of acute and chronic pain. The company's products are based on Tetrodotoxin (TTX), a sodium channel blocker. The clinical trial program of the company includes TEC-006 and TTX-CINP-201. TEC-006 is being studied for the treatment of moderate to severe cancer related pain and TTX-CINP-201 is being developed for moderate to severe neuropathic pain caused by chemotherapy in patients with cancer. It is a subsidiary of CK Life Sciences Int'l., (Holdings) Inc.

Reasons to Get this Report

* Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
* Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
* Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
* Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
WEX Pharmaceuticals Inc. - Key Facts
WEX Pharmaceuticals Inc. - Key Employees
WEX Pharmaceuticals Inc. - Major Products and Services
WEX Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data
WEX Pharmaceuticals Inc., Pipeline Products by Therapy Area
WEX Pharmaceuticals Inc., Pipeline Products by Development Phase
WEX Pharmaceuticals Inc. - History
WEX Pharmaceuticals Inc. - Locations And Subsidiaries
Head Office
Section 2 - Company Analysis
WEX Pharmaceuticals Inc. - Business Description
WEX Pharmaceuticals Inc. - SWOT Analysis
SWOT Analysis - Overview
WEX Pharmaceuticals Inc. - Strengths
Strength - Platform Technology-Tetrodotoxin
Strength - Strategic Alliances
WEX Pharmaceuticals Inc. - Weaknesses
Weakness - Lack of Marketed Products
WEX Pharmaceuticals Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Market Potential: Pain
WEX Pharmaceuticals Inc. - Threats
Threat - Industry Consolidation
Threat - Tightening of FDA's Regulatory Oversight
Threat - Uncertain R&D Outcomes
WEX Pharmaceuticals Inc. - Key Competitors
Section 3 - Company's Lifesciences Financial Deals and Alliances
WEX Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
WEX Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
WEX Pharmaceuticals Inc., Recent Deals Summary
Section 4 - Appendix
About GlobalData
Contact Us

List of Tables
WEX Pharmaceuticals Inc., Key Facts
WEX Pharmaceuticals Inc., Key Employees
WEX Pharmaceuticals Inc., Major Products and Services
WEX Pharmaceuticals Inc., Number of Pipeline Products by Therapy Area
WEX Pharmaceuticals Inc., Number of Pipeline Products by Development Stage
WEX Pharmaceuticals Inc., Pipeline Products By Therapy Area and Development Phase
WEX Pharmaceuticals Inc., History
WEX Pharmaceuticals Inc., Key Competitors
WEX Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
WEX Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014

Full Table of Contents is available at:

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 963 Words
Related Articles
More From Health
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo [..]
PromarkerD Predictive Diagnostics for DKD to Roll-out [..]
PERTH, AUSTRALIA, Mar 22, 2017 - (ACN Newswire) - Proteomics International Laboratories Ltd ('PILL'; ASX: PIQ), a world leader [..]
Do Prostalgene Drops Help To Restore Prostate [..]
Prostate enlargement is among the most common health problems for men over 50. With age the incidence of this condition [..]
Is OnycoSolve Spray The Key To Obliterating [..]
Toenail fungus is an undesirable but stubborn infection that comes with sweating, itching, cracking and scaling of the feet, inflammations, [..]
New Research reveals Asia poised as Preferred [..]
SYDNEY, Mar 10, 2017 - (ACN Newswire) - Frost & Sullivan has released its latest white paper, 'Asia: Preferred Destination for [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.